- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
HbA1c better predictor of post-stroke depression risk compared to fasting plasma glucose
China: Findings from a meta-analysis published in Neuroscience & Biobehavioral Reviews showed that higher peripheral blood glucose levels in the acute phase of stroke raise post-stroke depression (PSD) risk. Also, hemoglobin A1c (HbA1c) was found to be a better biomarker than fasting plasma glucose (FPG) for post-stroke depression risk.
A stroke is defined as a sudden blood supply loss to the brain resulting in permanent tissue damage caused by thrombotic, embolic, or hemorrhagic events. Post-stroke depression is a common psychiatric disorder that impacts patients' neurological recovery after a stroke. There is a requirement for particular biomarkers to predict post-stroke depression. Many previous studies have shown diabetes to be a predictor of post-stroke depression. However, there remains controversy on whether increased levels of FPG and HbA1c are tied to an elevated PSD risk.
Shaokuan Fang, Department of Neurology, Neuroscience Centre, the First Hospital of Jilin University, Changchun, China, and colleagues comprehensively searched databases for eligible studies. The relationship between peripheral blood glucose levels during the acute phase of stroke and PSD risk was examined using standard mean differences. When appropriate unadjusted or adjusted odds ratio (ORs) were available narrative syntheses and meta-analyses were conducted. The analysis included a total of 21 prospective cohort studies.
The study led to the following findings:
- PSD patients had significantly higher peripheral blood glucose levels than non-PSD patients (FPG: SMD, 0.28, HbA1c: SMD, 0.49 respectively).
- In the subgroup analyses by classifying the time point of depression assessment, HbA1c was more statistically significantly associated with the risk of PSD than FPG.
- Differences in the prevalence of diabetes were not heterogeneity sources.
"Higher peripheral blood glucose levels in the acute phase of stroke increase PSD risk," the researchers of the study wrote in their conclusion. "HbA1c might be a superior biomarker for the risk of PSD than FPG."
Fasting plasma glucose and hemoglobin A1c are both important potential predictors of post-stroke depression, the authors noted.
Reference:
Wang Y, Zhu L, Tan X, Cheng Y, Wang X, Fang S. Higher levels of peripheral blood glucose in the acute stage of stroke increase the risk of Post-stroke Depression: A Systematic Review and Meta-Analysis. Neurosci Biobehav Rev. 2022 Aug 12:104829. doi: 10.1016/j.neubiorev.2022.104829. Epub ahead of print. PMID: 35970415.
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751